BiotechTube
Home/Corbus Pharmaceuticals/Ian Hodgson, BSc (Hons), Ph.D.
IH

Ian Hodgson, BSc (Hons), Ph.D.

Chief Operating Officer

Corbus Pharmaceuticals

Therapeutic Areas

OncologyMetabolic DiseaseObesity

Corbus Pharmaceuticals Pipeline

DrugIndicationPhase
CRB-701Nectin-4 expressing solid tumors (e.g., HNSCC, Cervical Cancer, mUC)Phase 1
CRB-701 (CSPC)Cervical CancerPhase 3
CRB-913Obesity and related conditionsPhase 1

Leadership Team at Corbus Pharmaceuticals

YC
Yuval Cohen, Ph.D.
Chief Executive Officer and Director
SM
Sean Moran, CPA, MBA
Chief Financial Officer
DD
Dr. Dominic Smethurst, MA MRCP
Chief Medical Officer
View full Corbus Pharmaceuticals profile